Avinger (AVGR) Hits New 12-Month Low at $1.33

Avinger Inc (NASDAQ:AVGR)’s share price hit a new 52-week low on Monday . The company traded as low as $1.33 and last traded at $1.33, with a volume of 464100 shares traded. The stock had previously closed at $1.50.

Separately, Zacks Investment Research upgraded shares of Avinger from a “hold” rating to a “buy” rating and set a $10.00 target price for the company in a research report on Wednesday, January 3rd. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Avinger has a consensus rating of “Hold” and a consensus target price of $10.00.

The company has a market capitalization of $48.25, a PE ratio of -0.02 and a beta of -0.23.

WARNING: This story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/21/avinger-avgr-hits-new-12-month-low-at-1-33.html.

About Avinger

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply